Optibrium and Collaborative Drug Discovery are co-hosting this November event:
Advances in informatics technology are inspiring a new generation of innovative products that streamline and enhance the efficiency and productivity of drug discovery. Join us for this free event which brings together speakers at the forefront of drug research and development, and demonstrations of cutting-edge technologies for small molecule design, optimisation and data-analysis.
Dr Peter Monecke, Laboratory Head for in-silico Toxicology at Sanofi
Dr Lizbé Koekemoer, Post-doctoral Researcher at The Structural
Round Table discussions with:
Matt Segall, CEO, Optibrium
Barry Bunin, CEO, Collaborative Drug Discovery